Distinguishing aggressive versus nonaggressive prostate cancer using a novel prognostic proteomics biopsy test, ProMark.

• DOI: 10.1200/jco.2014.32.15_suppl.5090
• Publication Date: 2019-01-03T17:33:20Z
• Authors: Fred Saad; Michail Shipitsin; Sibgat Choudhury; Teresa Capela; Christina Ernst; Aeron Hurley; Clayton Small; Alexander Kaprely...; Sadiq Hussain; Hua Chang; Eldar Giladi; James Dunyak; Louis Coupal; Thomas Nifong; Mathieu Latour; David Berman; Peter Blume-Jensen
• Keywords: 03 medical and health sciences; 0302 clinical medicine; 3. Good health

5090 Background: Current clinical and pathological parameters are insufficient for accurate prediction of progression risk for patients with biopsy Gleason grades 3+3 or 3+4. Reasons for this inclu...